No doubt, CXCR5 and/or CXCL13 blockade and specific G protein inhibition might prove to be effective therapeutic strategies to disrupt CXCR5 (and possibly CXCR4) signaling to abrogate PCa cell metastasis. The gene discussed is CXCR5; the disease is posterior cortical atrophy.